New center will foster data science research

Cornell’s Center for Data Science for Enterprise and Society, launching this fall and led by David Shmoys, will enhance research in the increasingly important field of data science.

Cornell partners in $10M poultry science grant

Cornell is co-leading a $9.95 million, five-year U.S. Department of Agriculture grant that aims to transform nutrition and water use in the poultry industry in order to improve its environmental impact and enhance human health.

Zinc-anode batteries prove their mettle

Cornell researchers have found a way to build a zinc-anode battery that not only has a high energy density, but is low cost and stable, and has a life cycle that can be significantly prolonged.

Fluorescent probes offer fuller view of drug delivery in cells

Selecting the most effective molecules for drug delivery can be a trial-and-error process, but Cornell engineers have developed a new technique that provides some precision.

AI tool detects global fashion trends

A new artificial intelligence tool developed by Cornell researchers scans millions of publicly available photos to effectively identify fashion trends around the world, as well as traditions and events with signature styles.

Digital agriculture workshop highlights radical collaborations

The third annual Cornell Digital Agriculture workshop, Oct. 30 in the Statler Hotel, will bring together stakeholders across disciplines to solve the biggest problems in agriculture and food systems.

To rid electric grid of carbon, shore up green energy support

Cornell and Northwestern engineers, and a federal economist, have created an energy model that aims to remove carbon power from the U.S. electric grid – replacing it with financially feasible green energy.

Art and science provide fertile ground for research, teaching

Research projects investigating the sounds of soil bring the fields of soil science, art, bioacoustics, entomology and other disciplines together, and blend creative practice with scientific inquiry.

Universal flu vaccine developed at Cornell nearing human trials

A universal influenza vaccine developed with the potential to be longer lasting and more effective than commercially available vaccines is destined for human clinical trials, thanks to a $17.9 million grant from the National Institute of Allergy and Infectious Diseases.